Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

25 Jul 2013 07:00

RNS Number : 0744K
Halma PLC
25 July 2013
Β 

ο»Ώ

Halma plc

Β 

AGM/Interim Management Statement

Β 

25 July 2013

Β 

Β 

Halma, the leading safety, health and environmental technology group is holding its 119th AGM later today and makes the following Interim Management Statement relating to the period 31 March 2013 to date, with the figures below relating to the first quarter's trading.

Β 

Trading since the start of the financial year has been in line with the Board's expectations.

Β 

Revenue during the first quarter was 13% ahead of last year including 6% organic growth at constant currency. Order intake was 103% of revenue. We continue to increase investment in R&D resources, people development and the expansion of our global footprint to support organic growth.

Β 

Revenue growth was achieved in all major regions, with good organic growth in Mainland Europe and Asia Pacific, the latter supported by a continued strong performance in China. Organic growth rates were lower in the UK and the USA.

Β 

Our Process Safety and Medical sectors performed well whilst Infrastructure Safety has continued to grow steadily.

Β 

Environmental & Analysis has traded in line with expectations. The reorganisation of certain Photonics and Water businesses in this sector is progressing well. This will be completed by the end of 2013 and reorganisation costs will be in line with our previous estimate of Β£1m.

Β 

There have been no material events or transactions during the period impacting the Group's financial position, which remains strong. We continue to identify potential acquisition opportunities which meet our strategic and financial criteria.

Β 

The half yearly results for the period ending 28 September 2013 are expected to be released on 19 November 2013.

Β 

Β 

For further information please contact:

Β 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Β 

Β 

Β 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

Β 

Β 

NOTE TO EDITORS

Β 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

Β 

Β·; Process Safety

Products which protect assets and people at work.

Β·; Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

Β 

Β·; Medical

Products used to improve personal and public health.

Β·; Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

Β 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

Β 

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

Β 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSZMGZNDDRGFZM
Date   Source Headline
21st Nov 20177:00 amRNSHalf-year Report
1st Nov 20177:00 amRNSAcquisition
4th Oct 20175:54 pmRNSDirector/PDMR Shareholding
28th Sep 20179:57 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSTrading Statement
11th Sep 201712:19 pmRNSDirector Declaration
7th Sep 20179:27 amRNSDirector Declaration
1st Sep 20175:08 pmRNSTotal Voting Rights
16th Aug 20174:02 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSAcquisition
1st Aug 201710:39 amRNSTotal Voting Rights
31st Jul 201712:00 pmRNSNotice of Board Change
20th Jul 20173:57 pmRNSResult of AGM
19th Jul 20172:21 pmRNSDirector Declaration
4th Jul 20173:39 pmRNSDirector/PDMR Shareholding
3rd Jul 201711:29 amRNSTotal Voting Rights
21st Jun 20175:22 pmRNSAnnual Financial Report
13th Jun 20177:00 amRNSFinal Results
1st Jun 20173:02 pmRNSTotal Voting Rights
30th May 201711:00 amRNSNotice of Results
2nd May 20173:39 pmRNSTotal Voting Rights
6th Apr 20179:00 amRNSNotice of Board change
3rd Apr 201711:12 amRNSTotal Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Audit Tender
1st Mar 201712:41 pmRNSTotal Voting Rights
13th Feb 20174:06 pmRNSHolding(s) in Company
1st Feb 201712:07 pmRNSTotal Voting Rights
9th Jan 20179:00 amRNSAcquisition of FluxData
3rd Jan 20174:02 pmRNSTotal Voting Rights
1st Dec 201611:37 amRNSTotal Voting Rights
28th Nov 20163:05 pmRNSDirector/PDMR Shareholding
24th Nov 20164:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:35 pmRNSDoc re. Half Yearly Report
22nd Nov 20167:00 amRNSHalf-year Report
1st Nov 20164:43 pmRNSTotal Voting Rights
5th Oct 20165:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:31 pmRNSTotal Voting Rights
29th Sep 201610:00 amRNSInvestor Event
27th Sep 20169:37 amRNSDirectorate Change
23rd Sep 20164:27 pmRNSDirectorate Change
1st Sep 20165:25 pmRNSTotal Voting Rights
22nd Aug 20163:54 pmRNSDirector/PDMR Shareholding
10th Aug 20163:26 pmRNSDirector/PDMR Shareholding
1st Aug 20169:00 amRNSTotal Voting Rights
28th Jul 20163:06 pmRNSDirector/PDMR Shareholding
21st Jul 20166:01 pmRNSResult of AGM
21st Jul 20167:00 amRNSAGM Trading Update
1st Jul 201612:58 pmRNSTotal Voting Rights
21st Jun 20162:38 pmRNSAnnual Financial Report
14th Jun 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.